Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Tech Scene: Australia.
Press releases published on July 30, 2025
TCG Process Honored as a Global 5-Star Technology & Service Provider by Insurance Business Magazine
EIN Presswire
·
July 30, 2025
SYDNEY, AUSTRALIA, July 30, 2025 /EINPresswire.com/ -- TCG Process, a provider of business process orchestration and automation software, today announced it has been named one of Insurance Business Magazine’s Global 5-Star Technology and Software …
FundedNext Launches AI Assistant 'Fundee', the First Prop Firm with Multilingual Voice AI Support
EIN Presswire
·
July 30, 2025
Supports 32 Languages to Bridge Global Access and Cultural Relevance, Redefining Client Support with AI-Powered Assistance AJMAN, DUBAI, UNITED ARAB EMIRATES, July 30, 2025 /EINPresswire.com/ -- FundedNext, a leading prop trading firm, launched its …
What’s New at investingLive: Smarter Tools, Sharper Insights
EIN Presswire
·
July 30, 2025
investingLive adds smart tools, real-time news, and deeper insights to help traders and investors make better decisions every day. LIMASSOL, CYPRUS, July 30, 2025 /EINPresswire.com/ -- As ForexLive.com transitions to investingLive.com, we're not just …
Ray Tubes Launches SELECT 12AU7 and CORE 12AU7 Vacuum Tubes
EIN Presswire
·
July 30, 2025
Vacuum tube company expands line-up with new-production 12AU7 tubes in both its CORE and SELECT Collections OAKLAND, CA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- Ray Tubes is pleased to announce that SELECT 12AU7 and CORE 12AU7 vacuum tubes …
Immutep Quarterly Activities Report Q4 FY25
GlobeNewswire
·
July 30, 2025
Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countries Trial-in-Progress poster for TACTI- …
Appendix 4C – Q4 FY25 Quarterly Cash Flow Report
GlobeNewswire
·
July 30, 2025
Highlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA) Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSA Presented additional analyses from the ATH434-201 trial …